Follow
William Villiers
William Villiers
Research Associate, King's College London
Verified email at kcl.ac.uk
Title
Cited by
Cited by
Year
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature
S Alimam, W Villiers, R Dillon, M Simpson, M Runglall, A Smith, ...
Blood Advances 5 (4), 1059-1068, 2021
132021
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial
J Othman, C Wilhelm-Benartzi, R Dillon, S Knapper, SD Freeman, ...
Blood Advances 7 (16), 4539-4549, 2023
92023
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML:: RARA in acute promyelocytic leukemia
W Villiers, A Kelly, X He, J Kaufman-Cook, A Elbasir, H Bensmail, ...
Nature communications 14 (1), 724, 2023
62023
Genomic correlates of outcome in a randomised comparison of CPX-351 and FLAG-Ida in high-risk acute myeloid leukaemia and myelodysplastic syndrome: results from the UK NCRI …
J Othman, R Dillon, C Wilhelm-Benartzi, S Knapper, LM Batten, J Canham, ...
Blood 140 (Supplement 1), 1036-1038, 2022
32022
Long-range regulatory interactions in acute promyelocytic leukemia
W Villiers
King's College London, 2021
2021
Patients with triple-negative, JAK2V617F-and CALR-mutated essential thrombocythemia share a unique gene expression signature (vol 5, pg 1059, 2021)
S Alimam, W Villiers, R Dillon
BLOOD ADVANCES 5 (12), 2575-2575, 2021
2021
JAK2V617F-and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021; 5 (4): 1059-1068.
S Alimam, W Villiers, R Dillon
2021
Untangling the Transcriptional Mis-Regulation Driven By Pml; rara
W Villiers, P Lavender, A Kelly, M Lim, C Osborne, R Dillon
Blood 134, 282, 2019
2019
Molecular, Epigenetic and Gene Expression Profiling of Triple Negative Essential Thrombocythaemia
S Alimam, W Villiers, R Dillon, M Simpson, AE Smith, P Lavender, ...
Blood 134, 308, 2019
2019
A Randomised Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS
J Othman, CS Wilhelm-Benartzi, R Dillon, S Knapper, SD Freeman, ...
The system can't perform the operation now. Try again later.
Articles 1–10